MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions

The anti-tumor efficacy of miR-340 has been recently characterized in cancers. However, the underlying mechanisms of miR-340 inhibited cell growth and invasion in triple-negative breast cancer (TNBC) have not been well elucidated. In this study, we found that miR-340 expression was negatively correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Zhendong, Li, Yang, Qian, Xiaomin, Hu, Yunhui, Liu, Jingjing, Zhang, Sheng, Zhang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604455/
https://www.ncbi.nlm.nih.gov/pubmed/28928895
http://dx.doi.org/10.7150/jca.19315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604455/
https://www.ncbi.nlm.nih.gov/pubmed/28928895
http://dx.doi.org/10.7150/jca.19315

Ejemplares similares